Expression and clinical significance of FAM83A in breast cancer tissues and lymph node metastasis

This study aimed to investigate the expression pattern of FAM83A in primary breast cancer tissues and its association with clinicopathological characteristics, including lymph node metastasis. A total of 70 breast cancer specimens and 20 paired adjacent normal tissue samples were collected, FAM83A expression was examined in primary breast cancer tissues. Patients were subsequently divided into two groups based on their lymph node metastasis status: N0 (without lymph node metastasis) and N+ (with lymph node metastasis). The association between FAM83A expression in primary tumors and lymph node metastasis status was then analyzed.Immunohistochemistry was performed to assess the expression level of FAM83A in all collected tissues. Of the 70 breast cancer cases, 61 (87.1%) were positive for FAM83A expression, whereas no or weak staining was observed in adjacent normal tissues. FAM83A positivity was observed in 89.5% (34/38) of patients without lymph node metastasis and 84.4% (27/32) of those with lymph node metastasis, with no statistically significant difference between the two groups ( P = 0.529). FAM83A expression was significantly associated with estrogen receptor (ER) status ( P = 0.007), but not with age, T stage, or lymph node metastasis. FAM83A is highly expressed in breast cancer tissues and is associated with ER status, suggesting its potential as a candidate biomarker for breast cancer. However, its expression was not significantly correlated with lymph node metastasis in this cohort. Further functional studies are warranted to elucidate the biological role of FAM83A in breast cancer pathogenesis.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-15
DOI
https://doi.org/10.1007/s12672-026-06295-0
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Expression and clinical significance of FAM83A in breast cancer tissues and lymph node metastasis

Jie Hu, Zhiwei Tan, Yulan Liu, Lu Ye et al.
1 links
Discover Oncology
Breast Cancer Treatment Studies
article

Expression and clinical significance of FAM83A in breast cancer tissues and lymph node metastasis

Jie Hu, Zhiwei Tan, Yulan Liu, Lu Ye, Shigao Chen, Jinrong Chen, Yinghong Yu, Shuaijun Zhang
article en

Abstract

This study aimed to investigate the expression pattern of FAM83A in primary breast cancer tissues and its association with clinicopathological characteristics, including lymph node metastasis. A total of 70 breast cancer specimens and 20 paired adjacent normal tissue samples were collected, FAM83A expression was examined in primary breast cancer tissues. Patients were subsequently divided into two groups based on their lymph node metastasis status: N0 (without lymph node metastasis) and N+ (with lymph node metastasis). The association between FAM83A expression in primary tumors and lymph node metastasis status was then analyzed.Immunohistochemistry was performed to assess the expression level of FAM83A in all collected tissues. Of the 70 breast cancer cases, 61 (87.1%) were positive for FAM83A expression, whereas no or weak staining was observed in adjacent normal tissues. FAM83A positivity was observed in 89.5% (34/38) of patients without lymph node metastasis and 84.4% (27/32) of those with lymph node metastasis, with no statistically significant difference between the two groups ( P = 0.529). FAM83A expression was significantly associated with estrogen receptor (ER) status ( P = 0.007), but not with age, T stage, or lymph node metastasis. FAM83A is highly expressed in breast cancer tissues and is associated with ER status, suggesting its potential as a candidate biomarker for breast cancer. However, its expression was not significantly correlated with lymph node metastasis in this cohort. Further functional studies are warranted to elucidate the biological role of FAM83A in breast cancer pathogenesis.

Discover Oncology
Chengdu Medical College (CN), Sichuan University (CN), West China Medical Center of Sichuan University (CN), West China Second University Hospital of Sichuan University (CN), Chengdu Second People's Hospital (CN)
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon